Company Filing History:
Years Active: 2023
Title: David Primer - Innovator in Bromodomain Inhibitor Synthesis
Introduction
David Primer is an accomplished inventor based in Summit, NJ (US). He has made significant contributions to the field of chemical synthesis, particularly in the development of bromodomain inhibitors. His innovative work has led to the creation of a scalable method for synthesizing highly pure final products.
Latest Patents
David Primer holds a patent for a process related to the preparation of a bromodomain inhibitor. The patent, titled "Process for the preparation of bromodomain inhibitor," outlines methods for the synthesis and purification of Compound 1. This compound includes various forms such as crystalline, amorphous, solvates, and hydrates. The disclosed methods provide efficient chemical synthesis routes that ensure a high level of purity in the final product. Additionally, the patent describes techniques for isolating the most stable polymorph of Compound 1 through crystallization from formic acid and water. He has 1 patent to his name.
Career Highlights
David Primer is currently employed at Celgene Quanticel Research, Inc., where he continues to advance his research in chemical synthesis. His work has been instrumental in developing innovative solutions in the pharmaceutical industry.
Collaborations
David has collaborated with notable colleagues, including John Fitzgerald Traverse and Kelvin Hin-Yeong Yong. These partnerships have contributed to the success of his research and the advancement of their shared goals in the field.
Conclusion
David Primer is a notable inventor whose work in the synthesis of bromodomain inhibitors has made a significant impact in the pharmaceutical sector. His innovative approaches and collaborations continue to drive advancements in chemical synthesis.